207 related articles for article (PubMed ID: 8304046)
41. Interaction of androgen and 1,25-dihydroxyvitamin D3: effects on normal rat bone cells.
Gray C; Colston KW; Mackay AG; Taylor ML; Arnett TR
J Bone Miner Res; 1992 Jan; 7(1):41-6. PubMed ID: 1549957
[TBL] [Abstract][Full Text] [Related]
42. Short-term treatment of rats with high dose 1,25-dihydroxyvitamin D3 stimulates bone formation and increases the number of osteoblast precursor cells in bone marrow.
Erben RG; Scutt AM; Miao D; Kollenkirchen U; Haberey M
Endocrinology; 1997 Nov; 138(11):4629-35. PubMed ID: 9348188
[TBL] [Abstract][Full Text] [Related]
43. Phenotype-associated changes in the effects of 1,25-dihydroxyvitamin D3 on alkaline phosphatase and bone GLA-protein of rat osteoblastic cells.
Spiess YH; Price PA; Deftos JL; Manolagas SC
Endocrinology; 1986 Apr; 118(4):1340-6. PubMed ID: 3485045
[TBL] [Abstract][Full Text] [Related]
44. 1,25-Dihydroxyvitamin D3 interaction with dexamethasone and retinoic acid: effects on procollagen messenger ribonucleic acid levels in rat osteoblast-like cells.
Kim HT; Chen TL
Mol Endocrinol; 1989 Jan; 3(1):97-104. PubMed ID: 2915650
[TBL] [Abstract][Full Text] [Related]
45. The effects of IGF-I and IGF-II on proliferation and differentiation of human osteoblasts and interactions with growth hormone.
Langdahl BL; Kassem M; Møller MK; Eriksen EF
Eur J Clin Invest; 1998 Mar; 28(3):176-83. PubMed ID: 9568461
[TBL] [Abstract][Full Text] [Related]
46. Inorganic polyphosphate in human osteoblast-like cells.
Leyhausen G; Lorenz B; Zhu H; Geurtsen W; Bohnensack R; Müller WE; Schröder HC
J Bone Miner Res; 1998 May; 13(5):803-12. PubMed ID: 9610744
[TBL] [Abstract][Full Text] [Related]
47. Aluminum stimulates the proliferation and differentiation of osteoblasts in vitro by a mechanism that is different from fluoride.
Lau KH; Yoo A; Wang SP
Mol Cell Biochem; 1991 Jul; 105(2):93-105. PubMed ID: 1922012
[TBL] [Abstract][Full Text] [Related]
48. In vitro effect of 1,25-dihydroxyvitamin D3 on proliferation and collagen synthesis by bone marrow fibroblasts.
Wang JC
Acta Haematol; 1992; 88(1):27-31. PubMed ID: 1414158
[TBL] [Abstract][Full Text] [Related]
49. Differential effects of 1,25-dihydroxyvitamin D3-analogs on osteoblast-like cells and on in vitro bone resorption.
van den Bemd GJ; Pols HA; Birkenhäger JC; Kleinekoort WM; van Leeuwen JP
J Steroid Biochem Mol Biol; 1995 Dec; 55(3-4):337-46. PubMed ID: 8541230
[TBL] [Abstract][Full Text] [Related]
50. Effects of 1,25-dihydroxyvitamin D3 on osteoblastic MC3T3-E1 cells.
Kurihara N; Ishizuka S; Kiyoki M; Haketa Y; Ikeda K; Kumegawa M
Endocrinology; 1986 Mar; 118(3):940-7. PubMed ID: 3004901
[TBL] [Abstract][Full Text] [Related]
51. Stimulation of interleukin-4 of cell proliferation and mRNA expression of alkaline phosphatase and collagen type I in human osteoblast-like cells of trabecular bone.
Nohtomi K; Sato K; Shizume K; Yamazaki K; Demura H; Hosoda K; Murata Y; Seo H
Bone Miner; 1994 Oct; 27(1):69-79. PubMed ID: 7849548
[TBL] [Abstract][Full Text] [Related]
52. Abnormal response of osteoblasts from Hyp mice to 1,25-dihydroxyvitamin D3.
Yamamoto T; Ecarot B; Glorieux FH
Bone; 1992; 13(3):209-15. PubMed ID: 1322149
[TBL] [Abstract][Full Text] [Related]
53. Dexamethasone enhances the osteogenic effects of fluoride in human TE85 osteosarcoma cells in vitro.
Takada J; Chevalley T; Baylink DJ; Lau KH
Calcif Tissue Int; 1996 May; 58(5):355-61. PubMed ID: 8661971
[TBL] [Abstract][Full Text] [Related]
54. Vitamin K2 promotes 1alpha,25(OH)2 vitamin D3-induced mineralization in human periosteal osteoblasts.
Koshihara Y; Hoshi K; Ishibashi H; Shiraki M
Calcif Tissue Int; 1996 Dec; 59(6):466-73. PubMed ID: 8939773
[TBL] [Abstract][Full Text] [Related]
55. Phenytoin and fluoride act in concert to stimulate bone formation and to increase bone volume in adult male rats.
Ohta T; Wergedal JE; Matsuyama T; Baylink DJ; Lau KH
Calcif Tissue Int; 1995 May; 56(5):390-7. PubMed ID: 7621347
[TBL] [Abstract][Full Text] [Related]
56. Regulation of osteogenic differentiation of human bone marrow stromal cells: interaction between transforming growth factor-beta and 1,25(OH)(2) vitamin D(3) In vitro.
Liu P; Oyajobi BO; Russell RG; Scutt A
Calcif Tissue Int; 1999 Aug; 65(2):173-80. PubMed ID: 10430653
[TBL] [Abstract][Full Text] [Related]
57. Increased potency of 1,25-dihydroxyvitamin D3 on human osteoblast-like cells following structural side-chain modification.
Evans DB; Thavarajah M; Uskokovic MR; Kanis JA
Bone; 1990; 11(6):439-43. PubMed ID: 2078438
[TBL] [Abstract][Full Text] [Related]
58. 1,25-Dihydroxyvitamin D3, recombinant human transforming growth factor-beta 1, and recombinant human bone morphogenetic protein-2 induce in vitro differentiation of canine osteosarcoma cells.
Nozaki K; Kadosawa T; Nishimura R; Mochizuki M; Takahashi K; Sasaki N
J Vet Med Sci; 1999 Jun; 61(6):649-56. PubMed ID: 10423687
[TBL] [Abstract][Full Text] [Related]
59. 25-Hydroxy- and 1α,25-Dihydroxycholecalciferol Have Greater Potencies than 25-Hydroxy- and 1α,25-Dihydroxyergocalciferol in Modulating Cultured Human and Mouse Osteoblast Activities.
Zarei A; Hulley PA; Sabokbar A; Javaid MK; Morovat A
PLoS One; 2016; 11(11):e0165462. PubMed ID: 27893751
[TBL] [Abstract][Full Text] [Related]
60. Isolation and hormonal responsiveness of primary cultures of human bone-derived cells: gender and age differences.
Katzburg S; Lieberherr M; Ornoy A; Klein BY; Hendel D; Somjen D
Bone; 1999 Dec; 25(6):667-73. PubMed ID: 10593411
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
